iRay Group (SHA:688301)

China · Delayed Price · Currency is CNY

83.20

-0.52 (-0.62%)

Sep 30, 2026, 3:00 PM CST

Market Cap	26.06B +15.0%
Revenue (ttm)	2.86B +52.5%
Net Income	721.10M +46.5%
EPS	2.41 +39.9%
Shares Out	313.28M
PE Ratio	34.57
Forward PE	26.91
Dividend	0.71 (0.86%)
Ex-Dividend Date	Jun 12, 2026

Volume	3,347,040
Open	84.65
Previous Close	83.72
Day's Range	82.66 - 85.10
52-Week Range	68.29 - 153.29
Beta	0.94
Analysts	Strong Buy
Price Target	125.17 (+50.45%)
Earnings Date	Oct 30, 2026

About iRay Group

iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components and micro-display backplanes for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation detecting materials; software; and other products. It is also involved in t... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2011

Employees 2,411

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688301

Full Company Profile

Financial Performance

In 2025, iRay Group's revenue was 2.25 billion, an increase of 22.90% compared to the previous year's 1.83 billion. Earnings were 650.01 million, an increase of 39.73%.

Financial Statements

Analyst Summary

According to 10 analysts, the average rating for 688301 stock is "Strong Buy." The 12-month stock price target is ¥125.17, which is an increase of 50.45% from the latest price.

Price Target

¥125.17

(50.45% upside)

Analyst Consensus: Strong Buy

Stock Forecasts